The protocol for a randomized, sham-controlled trial of transcutaneous auricular neurostimulation for chronic pain and opioid withdrawal symptoms during a 4-day opioid taper for adults in the United States
The protocol for a randomized, sham-controlled trial of transcutaneous auricular neurostimulation for chronic pain and opioid withdrawal symptoms during a 4-day opioid taper for adults in the United States
Navid Khodaparast, Kathryn A. Cunningham, Denise Wilkes, Savannah Rodriguez et al.
Journal
Trials
Topics
Pain Management and Treatment
article
The protocol for a randomized, sham-controlled trial of transcutaneous auricular neurostimulation for chronic pain and opioid withdrawal symptoms during a 4-day opioid taper for adults in the United States
Navid Khodaparast, Kathryn A. Cunningham, Denise Wilkes, Savannah Rodriguez, Melanie A. McWade, David C. Houghton, Chris Pierson, Yong‐Fang Kuo, Victoria L. Korschgen
article en
Abstract
No abstract available for this paper.
Publication Tag
TrialsVol. 26(1)
Institutions
Spark Therapeutics (United States) (US), Sierra BioMedical (United States) (US), The University of Texas Medical Branch at Galveston (US)